In this study, we first used qRT-PCR and Western blotting for detecting the mRNA and protein levels of GRHL2 in acute leukemia patients and cell lines and found that the GRHL2 expression level is significantly lower in patients with acute leukemia and cell lines than that in normal controls. The gene discussed is GRHL2; the disease is acute leukemia.